key: cord-0874495-qm8tbgzg authors: Vipat, V.; Jadhav, S.; Saha, U.; Jadhav, S. Y.; Bhardwaj, S.; Choudhary, M. L .; Cherian, S.; Abraham, P.; Potdar, Varsha title: Detection of SARS-CoV-2 variants in India from UK returnees date: 2021-06-23 journal: Infection DOI: 10.1007/s15010-021-01617-6 sha: ee28b696c360c334a4df0006575714a1c8d0c93f doc_id: 874495 cord_uid: qm8tbgzg nan including Australia, Canada, Hong Kong SAR, Israel, Japan, Jordan, Lebanon, South Korea, and Singapore. Genomic analysis revealed that this new variant of SARS CoV-2 in a lineage named as B.1.1.7 branched-out from the rest of the phylogenetic tree [2] . The U.K. lineage of SARS-CoV-2 has picked 17 mutations that lead to 14 amino acid changes in multiple proteins and 3 deletions [2] . Crucial mutations were in the gene that encodes the spike, a protein on the viral surface that the pathogen uses to enter human cells. The Government of India (GoI) had suspended air travel from the UK since December 23, 2020, in order to check the influx of the new variant of SARS-CoV-2 into the country. Further, to monitor the spread of the UK variant in the country, GoI released a guideline wherein the respective State governments need to ensure that all passengers travelling from or transiting through airports in the UK and disembarking in India need be subjected to the RT-PCR test for SARS-CoV-2 on arrival. Further on, the samples of passengers testing positive should be sent to the Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune or any other appropriate laboratory for genomic sequencing. December 23, 2020 onwards, ICMR-NIV, Pune started receiving samples of the COVID-19 positive UK [1] . The tri target (ORF1ab, N, S) COVID-19 TaqPath assay from Thermo Fischer has been reported by the UK investigators to have S-gene dropout for this deletion [1] . The S-gene is generally not used by itself for detection of the virus hence S-gene drop-out is unlikely to cause an overall false-negative result for SARS-CoV-2 detection. However, S-gene drop-out can be used as a proxy measure of the incidence of the variant. Further, all the COVID-19 positive and S-gene drop-out samples were analysed for the whole genome using Ion Torrent NGS platform. The phylogenetic tree was constructed using MEGA v.6 [3] , employing the Neighbor-Joining method with "Maximum Composite Likelihood" as the substitution model and 1,000 bootstrap replications. For each whole-genome sequence, the Global Initiative on Sharing All Influenza Data (GISAID) Clade Assignment, was done using CoVsurver: Mutation Analysis of hCoV-19 (https:// www. gisaid. org/ epiflu-appli catio ns/ covsu rver-mutat ions-app/). For lineage assignment, the web application, Phylogenetic Assignment of Named Global Outbreak LINeages (PangoLIN) COVID-19 Lineage Assigner (https:// pango lin. cog-uk. io/), was implemented [4] . There are at least 3 designations for the nomenclatures of the SARS-CoV-2 strains in use [5] . Studies that describe the geographic distribution of SARS-CoV-2 clades and variants across the world using whole-genome sequencing have revealed that the GISAID clades G, GH and GR were predominant particularly in Europe and North America. In the United Kingdom, two new SARS-CoV-2 lineages with the N501Y mutation in the receptor-binding domain (RBD) of the spike protein spread rapidly [6] . An earlier 501Y lineage without amino acid deletion Δ69/Δ70, circulated mainly between early September and mid-November, and was ~ 10% more transmissible than the 501N lineage. Further, a 501Y lineage with amino acid deletion Δ69/Δ70, circulated since late September, and was ~ 75% more transmissible than the 501N lineage. These newly emerged SARS-CoV-2 variants within the GISAID GR clade were referred to as UK-variant 1 and variant 2 (VOC 202012/01) (B.1.1.7 in the Pango-LIN lineage classification). In addition to VOC 202012/01, South Africa reported another SARS-CoV-2 variant within the GISAID GH clade, designated as 501.V2 (B.1.351 in PangoLIN lineage classification), during October 2020, which is also of potential concern [1]. Additionally, P.1 and P.2 lineages, aliases of lineage B. 1.1.28.1 and B.1.1.28.2 respectively, within the GISAID GR clade, were first identified in Brazil during December 2020 [1] . The South Africa and Brazilian P.1 variants possessed E484K and N501Y along with K417N/T in the spike protein RBD which are of biological significance. The Brazilian P.2 variant had only E484K. Asian countries, including India had the early diverged clades namely S, L and V in addition to the G-type of clades [7] . Because of either insufficient viral RNA for genomic analysis or insufficient sample, the sequencing could not be performed for 58 COVID-19 of the 212 positive samples. Additionally, fourteen samples were rejected due to nonavailability of travel/clinical history. As of January 14, 2021, the whole genome sequencing and analysis were undertaken for totally 140 samples of COVID-19 positive and S-gene drop-outs. Sequences from 29 samples could not be considered due to low quality and 18 were excluded from the phylogenetic analysis due to short sequence length. Out of the 93 sequences considered (Table S1) , 30 (29 UK returnees and one contact) were positive for the SARS CoV-2 UK variant and belonged to lineage B.1.1.7 within the clade GR (Fig. 1) . Five sequences, three from Maharashtra and one from Punjab and Kerala each were classified as B.1.177 (GV clade) which to the best of our knowledge are among the first reported GV strains in India. Among the detected cases Fig. 1 Phylogenetic tree of selected whole-genome sequences of SARS-CoV-2 in this study (n = 93) along with Wuhan Hu-1 and other reference strains of major variants using the Neighbor-Joining method. Strains identified as the UK variants are shown in blue color ◂ of SARS CoV-2 UK variant, 10 were from Kerala, 8 were from Maharashtra, 5 from Gujarat, 3 each from Odisha and Tamil Nadu and one from Goa (Fig. 2) Most of the new candidate vaccines are based on the spike protein sequence. Therefore, it is essential to monitor variations in the spike protein among the circulating SARS-CoV-2 strains and assess possible antigenic changes. However, available evidences and report from other different mutations in the spike RBD do not appear to have a significant impact on the ability of antibodies in the sera from subjects vaccinated with mRNA-based vaccine to neutralise such variants [https:// www. ema. europa. eu/ en/ docum ents/ asses sment-report/ comir natyepar-public-asses sment report_ en. pdf]. Studies towards understanding the infectivity and pathogenicity of the UK SARS CoV-2 variant in India would however need to be pursued. There is currently a lack of evidence indicating that the UK SARS CoV-2 variant virus mentioned in this report is widespread in India. Given that sequencing performed still is in low numbers, therefore it is probable that there may be substantial under-detection. Nonetheless considering the extent to which the new variants of concern are circulating, efficient implementation of non-pharmaceutical measures in response to the epidemiological situation remains essential. Hygiene rules for prevention of transmission of SARS-CoV-2 remain effective even for the UK-variant and other variants of concern. This would be vital until and unless vaccination is shown to mitigate their impact. The online version contains supplementary material available at https:// doi. org/ 10. 1007/ s15010-021-01617-6. Assessment: Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA -first update Fast-spreading UK. virus variant raises alarms Molecular Evolutionar y Genetics Analysis version 6.0 A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology The WHO European Region sequencing laboratories and GISAID EpiCoV group. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region Distribution of the variants in the different Indian states based on the sequences of 93 samples from the UK returnees and few contacts Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom Genomic analysis of SARS-CoV-2 strains among Indians returning from Iran & China, Italian tourists in India Phylogenetic classification of the whole genome sequences of SARS-CoV-2 from India and evolutionary trends Availability of data and material (data transparency) Available. Conflict of interest None. Consent for publication All authors agree for publication.